List of bibliographic references indexed by Albendazole (effets indésirables)
Number of relevant bibliographic references: 21.
[0-20] [
0 - 20][
0 - 21][
20-20][
20-40]
| Ident. | Authors (with country if any) | Title |
|---|
| 001123 (2016) |
Edward K. Thomsen [Papouasie-Nouvelle-Guinée] ; Nelly Sanuku [Papouasie-Nouvelle-Guinée] ; Manasseh Baea [Papouasie-Nouvelle-Guinée] ; Samson Satofan [Papouasie-Nouvelle-Guinée] ; Elit Maki [Papouasie-Nouvelle-Guinée] ; Bart Lombore [Papouasie-Nouvelle-Guinée] ; Mark S. Schmidt [États-Unis] ; Peter M. Siba [Papouasie-Nouvelle-Guinée] ; Gary J. Weil [États-Unis] ; James W. Kazura [États-Unis] ; Lawrence L. Fleckenstein [États-Unis] ; Christopher L. King [États-Unis] | Efficacy, Safety, and Pharmacokinetics of Coadministered Diethylcarbamazine, Albendazole, and Ivermectin for Treatment of Bancroftian Filariasis. |
| 003972 (2013) |
Yaya Ibrahim Coulibaly [Mali] ; Ilo Dicko [Mali] ; Modibo Keita [Mali] ; Mahamadou Minamba Keita [Mali] ; Moussa Doumbia [Mali] ; Adama Daou [Mali] ; Fadima Cheick Haidara [Mali] ; Moussa Hama Sankare [Mali] ; John Horton [Royaume-Uni] ; Caroline Whately-Smith [Royaume-Uni] ; Samba Ousmane Sow [Mali] | A Cluster Randomized Study of The Safety of Integrated Treatment of Trachoma and Lymphatic Filariasis in Children and Adults in Sikasso, Mali |
| 004B40 (2011) |
Francis Anto [Ghana] ; Victor Asoala ; Thomas Anyorigiya ; Abraham Oduro ; Martin Adjuik ; Patricia Akweongo ; Raymond Aborigo ; Langbong Bimi ; Joseph Amankwa ; Abraham Hodgson | Simultaneous administration of praziquantel, ivermectin and albendazole, in a community in rural northern Ghana endemic for schistosomiasis, onchocerciasis and lymphatic filariasis. |
| 004E80 (2011) |
A. Hoerauf [Allemagne] ; K. Pfarr ; S. Mand ; A Y Debrah ; S. Specht | Filariasis in Africa--treatment challenges and prospects. |
| 005640 (2010) |
R. Rajendran [Inde] ; I P Sunish ; A. Munirathinam ; V. Ashok Kumar ; B K Tyagi | Role of community empowerment in the elimination of lymphatic filariasis in south India. |
| 005F93 (2009) |
J. Horton [Royaume-Uni] | The development of albendazole for lymphatic filariasis. |
| 006991 (2008) |
Sharmini Gunawardena [Sri Lanka] ; Shalini Sri Ranganathan ; Rohini Fernandopulle | Pharmacovigilance through consumer feedback (reporting) in the mass treatment of lymphatic filariasis using diethylcarbamazine and albendazole in two districts of Sri Lanka. |
| 006B46 (2008) |
Taniawati Supali [Indonésie] ; Yenny Djuardi ; Kenneth M. Pfarr ; Heri Wibowo ; Mark J. Taylor ; Achim Hoerauf ; Jeanine J. Houwing-Duistermaat ; M. Yazdanbakhsh ; Erliyani Sartono | Doxycycline treatment of Brugia malayi-infected persons reduces microfilaremia and adverse reactions after diethylcarbamazine and albendazole treatment. |
| 007187 (2007) |
Michael P. Fay [États-Unis] ; Chiung-Yu Huang ; Nana A Y. Twum-Danso | Monitoring rare serious adverse events from a new treatment and testing for a difference from historical controls. |
| 007279 (2007) |
Caroline A. Grady [États-Unis] ; Madsen Beau De Rochars [Haïti] ; Abdel N. Direny [Haïti] ; Jean Nicolas Orelus [Haïti] ; Joyanna Wendt [États-Unis] ; Jeanne Radday [États-Unis] ; Els Mathieu [États-Unis] ; Jacquelin M. Roberts [États-Unis] ; Thomas G. Streit [États-Unis] ; David G. Addiss [États-Unis] ; Patrick J. Lammie [États-Unis] | Endpoints for Lymphatic Filariasis Programs |
| 007321 (2007) |
J A Rizzo [Brésil] ; C. Belo ; R. Lins ; G. Dreyer | Children and adolescents infected with Wuchereria bancrofti in Greater Recife, Brazil: a randomized, year-long clinical trial of single treatments with diethylcarbamazine or diethylcarbamazine-albendazole. |
| 007803 (2006) |
Alison Krentel [Indonésie] ; Peter Fischer ; Paul Manoempil ; Taniawati Supali ; Gérard Servais ; Paul Rückert | Using knowledge, attitudes and practice (KAP) surveys on lymphatic filariasis to prepare a health promotion campaign for mass drug administration in Alor District, Indonesia. |
| 007A47 (2006) |
B V Babu [Inde] ; K. Rath ; A S Kerketta ; B K Swain ; S. Mishra ; S K Kar | Adverse reactions following mass drug administration during the Programme to Eliminate Lymphatic Filariasis in Orissa State, India. |
| 008834 (2004) |
B V Babu [Inde] ; S K Kar | Coverage, compliance and some operational issues of mass drug administration during the programme to eliminate lymphatic filariasis in Orissa, India. |
| 008890 (2004) |
N. A. Kshirsagar [Inde] ; N. J. Gogtay [Inde] ; B. S. Garg [Inde] ; P. R. Deshmukh [Inde] ; D. D. Rajgor [Inde] ; V. S. Kadam [Inde] ; B. G Kirodian [Inde] ; N. S. Ingole [Inde] ; A. M. Mehendale [Inde] ; L. Fleckenstein [États-Unis] ; J. Karbwang [Suisse] ; J. K. Lazdins-Helds [Suisse] | Safety, tolerability, efficacy and plasma concentrations of diethylcarbamazine and albendazole co-administration in a field study in an area endemic for lymphatic filariasis in India |
| 008E07 (2003) |
| Report on active surveillance for adverse events following the use of drug co-administrations in the global programme to eliminate lymphatic filariasis. |
| 008E94 (2003) |
Steven I. Mclaughlin [États-Unis] ; Jeanne Radday ; Marie Carmel Michel ; David G. Addiss ; Michael J. Beach ; Patrick J. Lammie ; John Lammie ; Richard Rheingans ; Jack Lafontant | Frequency, severity, and costs of adverse reactions following mass treatment for lymphatic filariasis using diethylcarbamazine and albendazole in Leogane, Haiti, 2000. |
| 009346 (2002) |
Taniawati Supali [Indonésie] ; Is Suhariah Ismid ; Paul Rückert ; Peter Fischer | Treatment of Brugia timori and Wuchereria bancrofti infections in Indonesia using DEC or a combination of DEC and albendazole: adverse reactions and short-term effects on microfilariae. |
| 009356 (2002) |
R K Shenoy [Inde] ; T K Suma ; A. John ; S R Arun ; V. Kumaraswami ; L L Fleckenstein ; K. Na-Bangchang | The pharmacokinetics, safety and tolerability of the co-administration of diethylcarbamazine and albendazole. |
| 012D74 (????) |
M M Ismail [Sri Lanka] ; R L Jayakody ; G J Weil ; N. Nirmalan ; K S Jayasinghe ; W. Abeyewickrema ; M H Rezvi Sheriff ; H N Rajaratnam ; N. Amarasekera ; D C De Silva ; M L Michalski ; A S Dissanaike | Efficacy of single dose combinations of albendazole, ivermectin and diethylcarbamazine for the treatment of bancroftian filariasis. |
| 012F63 (????) |
S K Dunyo [Ghana] ; F K Nkrumah ; P E Simonsen | A randomized double-blind placebo-controlled field trial of ivermectin and albendazole alone and in combination for the treatment of lymphatic filariasis in Ghana. |
Pour manipuler ce document sous Unix (Dilib)
EXPLOR_STEP=$WICRI_ROOT/Wicri/Sante/explor/LymphedemaV1/Data/Main/Exploration
HfdIndexSelect -h $EXPLOR_AREA/Data/Main/Exploration/KwdFr.i -k "Albendazole (effets indésirables)"
HfdIndexSelect -h $EXPLOR_AREA/Data/Main/Exploration/KwdFr.i \
-Sk "Albendazole (effets indésirables)" \
| HfdSelect -Kh $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd
Pour mettre un lien sur cette page dans le réseau Wicri
{{Explor lien
|wiki= Wicri/Sante
|area= LymphedemaV1
|flux= Main
|étape= Exploration
|type= indexItem
|index= KwdFr.i
|clé= Albendazole (effets indésirables)
}}
| This area was generated with Dilib version V0.6.31.
Data generation: Sat Nov 4 17:40:35 2017. Site generation: Tue Feb 13 16:42:16 2024 |  |
